Languages: English. Tuberculosis (TB), one of the leading infectious disease killers worldwide, has long posed a challenge, ...

Researchers identified three new all-oral drug regimens that include at least one of two new drugs for treatment of ...

Over 200 visitors interacted with each other over themes of drug resistant tuberculosis, extra-pulmonary TB and developments ...

Tuberculosis remains one of the top infectious disease killers worldwide, a challenge amplified by drug-resistant forms of the disease. Now, in a major step forward, an international clinical trial ...

"Multidrug-resistant TB is a major global public health problem, affecting over 400,000 people each year. It is associated with significantly poorer outcomes than drug-susceptible TB," said ...

For 2007, the WHO estimated 511,000 cases of multidrug-resistant (MDR)-TB, representing approximately 5% of all TB cases worldwide. Extensively drug-resistant (XDR-TB) strains have been detected ...

The endTB trial is one of four recent randomized controlled trials testing new, shorter, and less toxic treatment regimens for drug-resistant TB. The trials are using two fairly new drugs— bedaquiline ...

Tuberculosis remains one of the top infectious disease killers worldwide, a challenge amplified by drug-resistant forms of the disease. Now, in a major step forward, an international clinical trial ...